John Jarad, MD
Geriatric Medicine · Port Huron, MINPI 1245235654
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,064 and has fallen 60.5% since, to $420 in 2025. Among geriatric medicine clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 212 payments — averaging $15.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$432
- Amgen$292
- Pfizer$268
- Johnson & Johnson$233
- Lilly USA, LLC$180
- AstraZeneca$143
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,194100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $432 |
| Amgen | 20 | $292 |
| Pfizer | 20 | $268 |
| Johnson & Johnson | 18 | $233 |
| Lilly USA, LLC | 12 | $180 |
| AstraZeneca | 10 | $143 |
| Astellas Pharma US Inc | 9 | $137 |
| Amarin Pharma, Inc. | 8 | $136 |
| Sanofi-aventis U.S. LLC | 7 | $132 |
| GSK | 8 | $126 |
| Bayer | 5 | $125 |
| AbbVie(2 entities) | 8 | $124 |
| Merck | 8 | $108 |
| Edwards Lifesciences | 1 | $91 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 4 | $64 |
| Boehringer Ingelheim | 4 | $62 |
| Novartis | 4 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $47 |
| Biogen | 2 | $33 |
| Avanir Pharmaceuticals, Inc. | 2 | $30 |
| Aimmune Therapeutics, Inc. | 2 | $29 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| Mylan Specialty L.p. | 2 | $25 |
| Boston Scientific | 1 | $25 |
| QOL Medical, LLC | 2 | $24 |
| Eisai Inc. | 1 | $23 |
| Exact Sciences | 1 | $18 |
| Seqirus USA Inc | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Gilead | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
| Nabriva Therapeutics, PLC | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $11 |
How this compares
$3,194 in reported general payments places this provider in the 90th percentile of 168 geriatric medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 629 | $571,244 |
| JardianceEmpagliflozin | 338 | $314,586 |
| OzempicSemaglutide | 174 | $205,998 |
| JanuviaSitagliptin Phosphate | 143 | $141,510 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 150 | $132,171 |
| MounjaroTirzepatide | 90 | $115,199 |
| JanumetSitagliptin Phos/Metformin Hcl | 99 | $104,164 |
| XareltoRivaroxaban | 119 | $102,912 |
| RybelsusSemaglutide | 40 | $77,035 |
| TrulicityDulaglutide | 35 | $64,026 |
| FarxigaDapagliflozin Propanediol | 63 | $63,782 |
| Invega SustennaPaliperidone Palmitate | 12 | $47,586 |
| Repatha SureclickEvolocumab | 31 | $34,907 |
| EntrestoSacubitril/Valsartan | 52 | $34,732 |
| CreonLipase/Protease/Amylase | 12 | $33,816 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $268 | $571,244629 claims |
| Boehringer IngelheimJardiance, Tradjenta | $62 | $343,443381 claims |
| Novo NordiskOzempic, Rybelsus | $432 | $283,033214 claims |
| MerckJanuvia, Janumet, Janumet Xr | $108 | $260,093264 claims |
| Lilly USA, LLCMounjaro, Trulicity | $180 | $179,225125 claims |
| Johnson & JohnsonXarelto, Invega Sustenna | $233 | $150,498131 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $126 | $144,100170 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $143 | $88,837128 claims |
| AbbVieCreon, Restasis, Linzess | $124 | $55,18753 claims |
| NovartisEntresto | $55 | $34,73252 claims |
| AmgenProlia | $292 | $24,25114 claims |
| Astellas Pharma US IncMyrbetriq | $137 | $22,87234 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 168 geriatric medicine providers in Michigan.
Other geriatric medicine in Port Huron
- Douglas KrausePort Huron$278
- Gerald DaneshvarHamtramck$23K
- Jailan ElayoubiDearborn$20K
- Grace JenqAnn Arbor$12K
- Afriyie GrayGrand Rapids$12K
- Bnan RazokyTroy$11K
- Saket SaxenaDetroit$11K
- Randolph SchumacherFlint$9K
- Ronald BarnettLivonia$7K
- Michael BurryLivonia$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.